The litigation funder backing a class action against engineering company UGL over disclosures related to the ballooning costs of its Ichthys power project could pocket up to 30 percent of any settlement or judgment, according to a court order.
Building material manufacturer Amaca and distributor Seltsam have lost their appeal of a $1.5 million judgment won by a NSW resident who developed mesothelioma after working with asbestos during the 60s and 70s.
Macmahon Holdings has agreed to pay $6.7 million to settle a shareholder class action alleging the mining company failed to provide adequate disclosures about the impact delays on a project for Rio Tinto in the Pilbara would have on its profitability.
Liquidators for failed labour hire business One Key Workforce are disputing a claim by the CFMMEU for wages owed to employees, saying the money should be given to them while they wind up the company.
A former employment partner at Norton Rose Fulbright may ask a Federal Court judge to recuse himself from a long-running dispute with the law firm, saying the judge’s previous comments had triggered a “reasonable apprehension” of bias.
Hytera Communications wants the Federal Court to block Motorola from accessing evidence in their patent war covered by Chinese laws prohibiting disclosure of state secrets or compromising the country’s cybersecurity.
A Gold Coast-based derivatives trading firm has lost a defamation case against an online investment forum over critical comments warning potential investors against using the company.
A unit of Fortescue Metals Group has won its bid for emails between Squire Patton Boggs and a unit of electricity provider TransAlta Energy relating to a disputed power purchase agreement, saying privilege was waived when the emails were forwarded to a third party.
The Australian has been hit with a $155,000 fine for publishing an article referring to the criminal convictions of CFMMEU official John Setka despite repeated warnings by prosecutors about prejudicing their blackmail case against the union boss.
A Federal Court judge has expressed her disbelief at a cross claim by generic drug maker Sandoz against Danish multinational H Lundbeck, as the court begins to weigh arguments over damages owed to Lundbeck in the long-running patent case over its blockbuster anti-depressant Lexapro.